Ketamine Completed Phase 2 Trials for Obsessive Compulsive Disorder (OCD) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02062658Extending Ketamine's Effects in OCD With Exposure and Response Prevention (EX/RP)
NCT01349231Ketamine Infusion for Obsessive-Compulsive Disorder